Depression in adults
Do omega-3s improve depression symptoms?
Trials and reviews suggest a possible small symptom effect, but confidence is limited and clinical importance remains uncertain. They do not establish omega-3 as a substitute for depression treatment.
Updated September 24, 2026 · Editorial attribution: PV Griscom, M.Sc. · Independent clinical review pending
The question behind the headline
Adults with major depression; varied EPA/DHA preparations versus placebo, often alongside other care.
What the finding does—and doesn’t—tell us
The 2021 Cochrane review judged the average symptom difference unlikely to be clinically meaningful. Formulation subgroup findings do not prove that a particular EPA ratio will work for a patient.
Read the underlying research.
- Omega-3 fatty acids for depression in adults · Cochrane, 2021 ↗
- Exploration of the optimized portrait of omega-3 polyunsaturated fatty acids in treating depression: A meta-analysis of randomized-controlled trials. · 2025 ↗
Selected sources, not an exhaustive reference list. Rating draws on published results and review summaries; no independent full systematic review has been conducted. Source publication dates may precede this page’s update date.
Three questions to take forward
- Was the study population similar to the person or situation I have in mind?
- Did it measure an outcome people feel or experience, or only a laboratory marker?
- How do formulation, usual care, absolute benefit and adverse effects change the interpretation?
Study doses describe experiments; they are not personal dosing advice. Explore safety and limitations ↗